Across the biotech industry, the demand for accelerated time to clinic, operational precision, and robust scalability has never been more critical. Developers face the complexity of solving a growing ...

The therapeutic landscape is shifting—and biomarkers are at the center of this transformation. In this exclusive session, we’ll spotlight high-impact protein targets including FOLR1, HER2, Claudin ...

Protein therapeutics play a pivotal role across the modern healthcare landscape, offering treatment options for a wide range of indications. To meet the increased demand for these therapies, it is ...